Characterizing the RNA targets and position-dependent splicing regulation by TDP-43 JR Tollervey, T Curk, B Rogelj, M Briese, M Cereda, M Kayikci, J König, ... Nature neuroscience 14 (4), 452-458, 2011 | 1228 | 2011 |
A Comprehensive Bioinformatics Analysis of UBE2C in Cancers H Dastsooz, M Cereda, D Donna, S Oliviero International Journal of Molecular Science 20 (9), 2228, 2019 | 96 | 2019 |
Both selective and neutral processes drive GC content evolution in the human genome U Pozzoli, G Menozzi, M Fumagalli, M Cereda, GP Comi, R Cagliani, ... BMC evolutionary biology 8, 1-12, 2008 | 89 | 2008 |
Synthetic lethal interaction between the tumour suppressor STAG2 and its paralog STAG1 L Benedetti, M Cereda, LA Monteverde, N Desai, FD Ciccarelli Oncotarget 8 (23), 37619, 2017 | 78 | 2017 |
RNAmotifs: prediction of multivalent RNA motifs that control alternative splicing M Cereda, U Pozzoli, G Rot, P Juvan, A Schweitzer, T Clark, J Ule Genome biology 15, 1-12, 2014 | 64 | 2014 |
Patients with genetically heterogeneous synchronous colorectal cancer carry rare damaging germline mutations in immune-related genes M Cereda, G Gambardella, L Benedetti, F Iannelli, D Patel, G Basso, ... Nature Communications 7 (1), 12072, 2016 | 52 | 2016 |
Clinical and molecular characterization of a cohort of patients with novel nucleotide alterations of the Dystrophin gene detected by direct sequencing F Magri, R Del Bo, MG D'Angelo, A Govoni, S Ghezzi, S Gandossini, ... BMC medical genetics 12, 1-12, 2011 | 48 | 2011 |
Patient-specific cancer genes contribute to recurrently perturbed pathways and establish therapeutic vulnerabilities in esophageal adenocarcinoma TP Mourikis, L Benedetti, E Foxall, D Temelkovski, J Nulsen, J Perner, ... Nature Communications 10 (1), 3101, 2019 | 40 | 2019 |
Gene function and expression level influence the insertion/fixation dynamics of distinct transposon families in mammalian introns M Sironi, G Menozzi, GP Comi, M Cereda, R Cagliani, N Bresolin, ... Genome biology 7, 1-15, 2006 | 35 | 2006 |
GeCo++: a C++ library for genomic features computation and annotation in the presence of variants M Cereda, M Sironi, M Cavalleri, U Pozzoli Bioinformatics 27 (9), 1313-1315, 2011 | 27 | 2011 |
Integrative genomic and transcriptomic analyses illuminate the ontology of HER2-low breast carcinomas E Berrino, L Annaratone, SE Bellomo, G Ferrero, A Gagliardi, A Bragoni, ... Genome Medicine 14 (1), 98, 2022 | 23 | 2022 |
Genetic redundancy, functional compensation, and cancer vulnerability M Cereda, TP Mourikis, FD Ciccarelli Trends in cancer 2 (4), 160-162, 2016 | 22 | 2016 |
Recessive cancer genes engage in negative genetic interactions with their functional paralogs M D’Antonio, RF Guerra, M Cereda, S Marchesi, F Montani, F Nicassio, ... Cell Reports 5 (6), 1519-1526, 2013 | 22 | 2013 |
A complex selection signature at the human AVPR1B gene R Cagliani, M Fumagalli, U Pozzoli, S Riva, M Cereda, GP Comi, L Pattini, ... BMC evolutionary biology 9, 1-14, 2009 | 18 | 2009 |
Omic approaches to pediatric bone sarcomas E Tirtei, M Cereda, E De Luna, P Quarello, SD Asaftei, F Fagioli Pediatric Blood & Cancer 67 (2), e28072, 2020 | 16 | 2020 |
Artificial intelligence in bulk and single-cell RNA-sequencing data to foster precision oncology M Del Giudice, S Peirone, S Perrone, F Priante, F Varese, E Tirtei, ... International journal of molecular sciences 22 (9), 4563, 2021 | 14 | 2021 |
Collision of germline POLE and PMS2 variants in a young patient treated with immune checkpoint inhibitors E Berrino, R Filippi, C Visintin, S Peirone, E Fenocchio, G Farinea, ... NPJ Precision Oncology 6 (1), 15, 2022 | 12 | 2022 |
FOXA1 regulates alternative splicing in prostate cancer M Del Giudice, JG Foster, S Peirone, A Rissone, L Caizzi, F Gaudino, ... Cell Reports 40 (13), 2022 | 11 | 2022 |
Apoptosis in mesenchymal stromal cells activates an immunosuppressive secretome predicting clinical response in Crohn’s disease TS Cheung, C Giacomini, M Cereda, A Avivar-Valderas, D Capece, ... Molecular Therapy 31 (12), 3531-3544, 2023 | 10 | 2023 |
Molecular characterization of prostate cancers in the precision medicine era EF Giunta, L Annaratone, E Bollito, F Porpiglia, M Cereda, GL Banna, ... Cancers 13 (19), 4771, 2021 | 10 | 2021 |